Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Ozempic, Wegovy, and Zepbound are prescription medications. Only a licensed medical provider can determine whether any of these medications are appropriate for your individual health profile. Results vary by individual. Compounded medications are not FDA-approved finished products. Always consult a licensed professional before starting any weight management program.
The best online programs for Ozempic, Wegovy, and Zepbound give you access to prescription GLP-1 medications without the traditional hurdles of waiting rooms, long referral timelines, and pharmacy lines. Telehealth has changed how patients get these medications, and the market has exploded to meet demand.
But here’s the reality: Ozempic, Wegovy, and Zepbound are brand-name medications. They’re not what most online programs actually dispense. What most telehealth clinics offer are compounded versions of the same active ingredients, which are semaglutide and tirzepatide, produced by licensed pharmacies at a fraction of the brand-name cost.
This guide explains the difference clearly. You’ll get a full comparison of the top providers, real 2026 pricing for both brand-name and compounded options, what the prescription process looks like, who qualifies, and what to expect in terms of results.
Here’s how the top programs stack up across the key categories that affect your decision.
| Provider | Ozempic/Wegovy (Semaglutide) | Zepbound (Tirzepatide) | Compounded Option | Starting Price | Insurance Help | Best For |
| InjectCo | Compounded semaglutide | Compounded tirzepatide | Yes (503B) | $249/month (sema) / $425/month (tirz) | No | TX patients, nurse-led care |
| Ro | Brand-name Wegovy | Brand-name Zepbound | Yes | $299/month+ | Yes (concierge) | Insurance users, brand-name access |
| Noom | Brand-name + compounded | Brand-name + compounded | Yes | Varies | Yes | Coaching + medication |
| Hims & Hers | Brand-name + compounded | Brand-name + compounded | Yes | ~$199/month+ | Limited | Budget-conscious patients |
| Mochi Health | Brand-name + compounded | Brand-name + compounded | Yes | Varies | Yes (in-network) | Insurance-heavy plans |
| Henry Meds | Compounded semaglutide | Compounded tirzepatide | Yes | ~$197/month+ | No | Fast access, compounded only |
| MEDVi | Brand-name + compounded | Compounded tirzepatide | Yes | ~$179/month+ | Limited | Board-certified MDs, budget |
Pricing reflects publicly available starting figures as of June 2026 and may vary by dose, location, and plan structure.
This isn’t a list of whoever runs the most ads. These rankings are based on criteria that reflect what patients actually experience after they sign up.
Here’s what we evaluated for each provider:
Every provider that made this list has a real consultation step, licensed prescribers, and a named pharmacy partner. Programs that skip any of these did not make the cut.
Here’s a closer look at each provider worth considering.
Overview: InjectCo is a nurse-led, physician-supervised medical clinic with 8 physical locations across Texas. Their telehealth program serves patients statewide through a virtual GLP-1 program. InjectCo offers compounded semaglutide (the active ingredient in Ozempic and Wegovy) and compounded tirzepatide (the active ingredient in Zepbound), not the brand-name versions themselves.
Pros:
Cons:
Pricing: Compounded semaglutide at $249/month. Compounded tirzepatide at $425/month. Both all-inclusive.
Prescription Process: Secure online medical form, licensed provider review, virtual consultation, approval, and monthly home delivery.
Best For: Texas patients who want nurse-led clinical oversight, verified 503B pharmacy sourcing, and the option of in-person follow-up.
Overview: One of the largest telehealth platforms in the US. Ro prescribes FDA-approved Wegovy and Zepbound and has an insurance concierge team that handles prior authorizations and appeals.
Pros:
Cons:
Pricing: Cash-pay Zepbound starts at $299/month through LillyDirect. Compounded options vary.
Best For: Patients with commercial insurance who want brand-name Wegovy or Zepbound and help navigating coverage.
Overview: Noom built its reputation on behavioral coaching before adding GLP-1 prescriptions. Their program combines psychology-based tools with clinical care.
Pros:
Cons:
Best For: Patients who want structured behavioral coaching alongside their medication.
Overview: A national direct-to-consumer telehealth brand that offers both compounded and brand-name GLP-1 medications at competitive starting prices.
Pros:
Cons:
Pricing: Compounded semaglutide starts around $199/month. Brand-name access varies.
Best For: Patients who prioritize low entry cost and don’t need deep clinical relationship management.
Overview: Mochi integrates insurance billing better than most telehealth platforms, working with in-network plans for both medication and nutritional support.
Pros:
Cons:
Best For: Patients with strong insurance coverage who want a comprehensive in-network program.
Overview: Henry Meds focuses on compounded GLP-1 medications at accessible prices with fast access through their telehealth platform.
Pros:
Cons:
Pricing: Compounded semaglutide starts around $197/month.
Best For: Self-pay patients who want quick, affordable access to compounded semaglutide.
| Patient Type | Best Pick | Why |
| Best Overall (TX) | InjectCo | Nurse-led, 503B sourcing, in-person backup |
| Best Budget | MEDVi or Henry Meds | Board-certified oversight, compounded only, under $200/month |
| Best for Insurance Users | Ro or Mochi Health | Concierge insurance support, brand-name access |
| Best Brand-Name Access | Ro | Wegovy and Zepbound both available, insurance help |
| Best Doctor Support | Ro or Mochi | Clinical + coaching + insurance integration |
| Best Ongoing Coaching | Noom | Behavioral platform + medication management |
| Best for Busy Professionals | InjectCo or Henry Meds | Fully virtual, all-inclusive, no extra appointments |
| Best for Long-Term Management | InjectCo or Noom | Ongoing monitoring, dose management, lifestyle structure |
Different patients have different priorities. Here’s a quick breakdown by patient type.
This section answers the most common question patients have before choosing a program. These are three different brand-name products, but the picture is more specific than most people realize.
Ozempic, Wegovy, and Zepbound are all GLP-1 medications. But they don’t all contain the same active ingredient, and they don’t all carry the same FDA approvals.
Ozempic is a brand-name injectable semaglutide made by Novo Nordisk. The FDA approved it in 2017 for the treatment of type 2 diabetes and for reducing cardiovascular risk in adults with type 2 diabetes and known heart disease. Ozempic doses go up to 2 mg weekly.
Ozempic is not FDA-approved for weight loss. It gets used for weight loss frequently because semaglutide does reduce appetite and body weight, but that’s considered off-label use. There is no dedicated Ozempic manufacturer cash-pay program for weight loss, which makes it one of the more expensive brand-name paths for non-diabetic patients.
Wegovy contains the same active ingredient as Ozempic, which is semaglutide, but at a higher dose and with a different FDA approval. Wegovy is approved for chronic weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition. It goes up to 2.4 mg weekly as an injection, and Novo Nordisk launched an oral tablet version in January 2026 starting at $149/month for lower doses.
In the STEP 1 clinical trial, adults on Wegovy lost an average of nearly 15% of their body weight over 68 weeks. Wegovy also carries FDA approval for reducing major cardiovascular events in adults with known heart disease and obesity or overweight, which no other GLP-1 weight loss medication currently has.
A new high-dose formulation (Wegovy HD at 7.2 mg) is also available, with STEP UP trial data showing an average weight loss of about 21% over 72 weeks.
Zepbound is tirzepatide, made by Eli Lilly. It’s a different active ingredient from Ozempic and Wegovy. Tirzepatide targets two hormones simultaneously, GIP and GLP-1, while semaglutide targets only GLP-1. That dual mechanism produces stronger weight loss outcomes in head-to-head data.
In the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine, tirzepatide achieved a weight loss of 20.2% compared to 13.7% with semaglutide over 72 weeks.
Zepbound is FDA-approved for chronic weight management. Cash-pay pricing through LillyDirect starts at $349/month for single-dose vials.
| Feature | Ozempic | Wegovy | Zepbound |
| Active Ingredient | Semaglutide | Semaglutide | Tirzepatide |
| Mechanism | GLP-1 agonist | GLP-1 agonist | Dual GIP + GLP-1 agonist |
| FDA Approval | Type 2 diabetes + CV risk | Chronic weight management + CV risk | Chronic weight management |
| Max Injectable Dose | 2 mg weekly | 2.4 mg (7.2 mg HD) weekly | 15 mg weekly |
| Oral Option | Yes (Ozempic tablets, Feb 2026) | Yes (Wegovy pill, Jan 2026) | No |
| Average Weight Loss | 6-7% (in T2D trials) | ~15% at 2.4 mg; ~21% at 7.2 mg | Up to 22.5% at 15 mg |
| Self-Pay Price (Retail) | ~$1,000/month | ~$1,350/month (injectable) | ~$1,000-$1,500/month |
| Cash-Pay Program | None for weight loss | $199-$349/month via NovoCare | $349-$499/month via LillyDirect |
| Cardiovascular Benefit | Yes (for T2D) | Yes (SELECT trial) | Under review |
The bottom line on naming: Most online programs advertising “Ozempic online” or “Wegovy online” are not dispensing those brand-name products. They’re prescribing compounded semaglutide, the same active ingredient at a fraction of the cost. InjectCo is one of those programs. What InjectCo offers is compounded semaglutide (for patients who would otherwise use Ozempic or Wegovy) and compounded tirzepatide (for patients considering Zepbound), both from a licensed 503B pharmacy.
Pricing varies more than most people expect. Here’s an honest breakdown of what you’ll actually pay in 2026, depending on which route you take.
Ozempic runs about $1,000/month at retail list price. Wegovy lists at $1,350/month but drops to $199/month for the first two fills through NovoCare’s self-pay program. Zepbound is available at $499/month through LillyDirect for single-dose vials.
In January 2026, Novo Nordisk launched an FDA-approved Wegovy pill, making it the first oral GLP-1 approved specifically for weight loss. The oral tablet starts at $149/month for lower starter doses, giving patients who dislike injections a new path.
| Medication Type | Typical Monthly Cost |
| Compounded semaglutide (licensed telehealth) | $179 to $299/month |
| Compounded tirzepatide (licensed telehealth) | $200 to $500/month |
| InjectCo compounded semaglutide | $249/month, all-inclusive |
| InjectCo compounded tirzepatide | $425/month, all-inclusive |
| Brand-name Wegovy (NovoCare cash-pay) | $199-$349/month |
| Brand-name Zepbound (LillyDirect) | $349-$499/month |
| Brand-name Ozempic (retail, no manufacturer cash program) | ~$1,000/month |
A few things affect your real monthly cost, not just the headline number.
Dose level. Starter doses cost less. At therapeutic maintenance doses, prices rise at most providers. Some programs advertising $99-$199/month apply only to the 2.5mg or 0.25mg starting step.
What’s bundled in. Consultation fees, lab work, and shipping can add $50-$200/month on top of a low-advertised medication price. Programs with flat all-inclusive pricing, like InjectCo, give you a clearer picture of actual cost.
503A vs. 503B pharmacy. 503B outsourcing facilities operate under stricter federal manufacturing standards and typically cost more. That difference in quality matters for consistency and sterility.
Coaching and support add-ons. Platforms like Noom charge for their behavioral coaching layer. It adds value for some patients and cost for others.
Yes. Most patients using online programs pay cash. Here’s how the options break down.
Compounded semaglutide and tirzepatide programs don’t involve insurance at all. You pay a monthly program fee and receive your medication. No prior authorization, no step therapy requirements, no claims.
For brand-name medications, Eli Lilly and Novo Nordisk both have direct cash-pay programs. Zepbound is available through LillyDirect at $349/month. Wegovy starts at $199/month for new patients through NovoCare’s introductory pricing.
Coverage for weight loss medications has improved but remains inconsistent. Most plans that cover Ozempic do so for type 2 diabetes, not weight loss. Wegovy and Zepbound coverage for obesity management varies widely by plan. Some large employers now cover these medications, and Medicare is expected to expand GLP-1 coverage for weight loss starting July 2026.
Platforms like Ro and Mochi Health have dedicated teams to help navigate prior authorizations and appeals. If coverage matters to you, using a platform with insurance concierge support saves significant time.
Medical weight loss programs may qualify for HSA or FSA reimbursement when the medication is prescribed for a qualifying condition. Whether your specific program qualifies depends on your plan administrator and how the service is categorized. Check out our breakdown on FSA/HSA eligibility for medical weight loss before assuming it applies.
Both Eli Lilly and Novo Nordisk run savings programs for commercially insured patients. Both Zepbound and Wegovy offer manufacturer savings cards that may reduce out-of-pocket costs to as little as $25 per month for eligible commercially insured patients, though these programs have strict eligibility rules. They don’t apply to Medicare or Medicaid, and for Wegovy, the savings card only works when your insurance covers the medication.
The process is similar across all legitimate programs. Here’s what to expect step by step.
You fill out a secure intake form covering your health history, current medications, prior weight loss attempts, and goals. This replaces the in-person office visit. Most forms take 10-15 minutes.
A licensed physician, nurse practitioner, or physician assistant reviews your intake and may schedule a brief virtual consultation. They assess your eligibility, ask follow-up questions, and screen for contraindications.
Your provider determines whether you qualify based on your BMI, medical history, and whether you have any conditions that rule out GLP-1 therapy.
If approved, the provider issues your prescription and sends it to a licensed pharmacy partner. For compounded programs, this goes to a 503A or 503B compounding pharmacy. For brand-name programs, it routes to a specialty pharmacy or directly through manufacturer programs.
Your medication ships to your address with cold-chain packaging. Most patients receive their first supply within 5-10 business days from approval.
Legitimate programs include follow-up check-ins to review progress, adjust doses, and manage side effects. This is where good programs separate from bad ones. A prescription and a package is not a program.
Eligibility follows the same general framework across providers. Your medical evaluation determines whether you qualify.
The standard FDA-approved thresholds for GLP-1 weight loss therapy are:
Ozempic for type 2 diabetes doesn’t require a weight-related BMI threshold, but the diabetes diagnosis itself is required for an on-label prescription.
Several health conditions make GLP-1 therapy clinically appropriate beyond BMI alone:
GLP-1 medications have real contraindications. You shouldn’t use them if you have:
Your provider reviews all of this during the evaluation. If you don’t qualify for one medication, you may qualify for another. A good program tells you the reason and offers alternatives when possible.
Results vary by medication, dose, adherence, and lifestyle factors. Here’s what the clinical data actually shows.
Ozempic (type 2 diabetes use): In adults with type 2 diabetes, semaglutide at Ozempic doses produces an average 6-7% weight loss. That’s meaningful for diabetes management but lower than weight-specific dosing.
Wegovy (weight loss indication): In clinical trials, adults receiving Wegovy had an average weight loss of nearly 15% of their initial body weight. At the new 7.2 mg high-dose formulation, the STEP UP trial showed a mean weight loss of 21% over 72 weeks in adults with obesity and without diabetes.
Zepbound (weight loss indication): Participants taking tirzepatide achieved average weight reductions of 16.0% at 5 mg, 21.4% at 10 mg, and 22.5% at 15 mg, compared to 2.4% for placebo, over 72 weeks in the SURMOUNT-1 trial.
Most patients notice changes on a predictable timeline:
No medication works identically for every patient. These variables shape your outcomes:
GLP-1 medications are well-studied. Their side effect profiles are documented across tens of thousands of trial participants.
The most frequent adverse events are gastrointestinal and usually mild to moderate in intensity.
All GLP-1 medications carry a boxed warning for thyroid C-cell tumors based on animal study data. The real-world risk in humans hasn’t been established, but it’s the reason providers screen for personal or family history of medullary thyroid carcinoma and MEN2 syndrome.
Other serious risks include pancreatitis, gallbladder disease, low blood sugar (particularly in patients on other diabetes medications), and kidney problems from dehydration caused by GI side effects.
Contact your provider immediately if you experience severe abdominal pain that doesn’t resolve, persistent vomiting, signs of allergic reaction, or significant vision changes. Don’t wait for your next scheduled check-in if something feels wrong.
With this many options, here’s a practical framework for narrowing it down before you commit.
Before signing up for any program, get clear answers to these:
Not every program that appears in search results is worth trusting. Watch for these warning signs:
Any one of these should give you pause. Multiple together means move on.
InjectCo doesn’t prescribe Ozempic, Wegovy, or Zepbound. Those are brand-name products made by Novo Nordisk and Eli Lilly. What InjectCo offers is compounded semaglutide and compounded tirzepatide, the same active ingredients used in those brand-name products, prepared by a licensed 503B pharmacy at a significantly lower cost.
For patients researching Ozempic or Wegovy online, compounded semaglutide is the accessible, clinically supervised alternative.
For patients researching Zepbound online, compounded tirzepatide covers the same dual GIP and GLP-1 mechanism at a lower monthly cost than the brand-name product.
Here’s what the InjectCo program includes:
Compounded semaglutide at $249/month:
Compounded tirzepatide at $425/month:
InjectCo is nurse-led, physician-supervised, and has treated 50,000+ patients across Texas. The clinical team carries 75+ combined years of experience. There are 8 physical locations available if you want in-person follow-up, which most national telehealth platforms cannot offer.
Financing through CareCredit and Cherry is available, with 0% APR options for qualifying patients.
Ready to compare your options or get started? View our semaglutide program or our tirzepatide program.
Call: (817) 533-7676 | Se habla español: (469) 804-9964
What is the best online Ozempic program in 2026? Most programs advertising “Ozempic online” prescribe compounded semaglutide, not the brand-name Ozempic from Novo Nordisk. For a nurse-led, 503B-sourced compounded semaglutide program in Texas, InjectCo starts at $249/month all-inclusive. For actual brand-name Ozempic, you’d need a type 2 diabetes diagnosis, and most providers route that through insurance.
What is the best online Wegovy program? Ro is the most straightforward path to brand-name Wegovy, with insurance concierge support and cash-pay access. NovoCare’s own program offers the first two months at $199/month for new self-pay patients. If you want compounded semaglutide as a cost-effective alternative with the same active ingredient, InjectCo at $249/month all-inclusive is a strong option.
What is the best online Zepbound program? Ro offers brand-name Zepbound with insurance support, and LillyDirect has cash-pay access starting at $349/month. InjectCo’s compounded tirzepatide program ($425/month) provides the same dual-mechanism active ingredient from a licensed 503B pharmacy with nurse-led oversight.
Can I legally get Ozempic online? Yes, with a valid prescription from a licensed provider and a legitimate pharmacy. No telehealth program can legally dispense Ozempic or any prescription medication without a proper medical evaluation and prescription. Any platform skipping that step is not operating legally.
Can I legally get Wegovy online? Yes. Licensed telehealth providers can prescribe Wegovy for eligible patients. You need a genuine medical evaluation confirming your eligibility (typically BMI 30+ or 27+ with a weight-related condition). The prescription goes to a licensed pharmacy, and the medication ships to your address.
Can I legally get Zepbound online? Yes. Zepbound requires a prescription from a licensed provider who has evaluated you and confirmed eligibility. Legitimate programs include a real consultation step. LillyDirect also sells Zepbound directly at cash-pay pricing for patients who have a valid prescription.
Which online weight loss clinic accepts insurance? Ro and Mochi Health have the most developed insurance infrastructure. Ro’s concierge team handles prior authorizations and appeals. Mochi works within in-network plans for comprehensive care. Most compounded programs, including InjectCo, do not accept insurance.
How much do Ozempic programs cost without insurance? Brand-name Ozempic runs about $1,000/month at list price with no manufacturer cash-pay program for weight loss. Compounded semaglutide programs range from $179 to $299/month. InjectCo’s all-inclusive program is $249/month.
How much does Wegovy cost without insurance? NovoCare’s introductory pricing starts at $199/month for new self-pay patients for the first two fills. After that, pricing moves to $349/month for most injectable doses. The oral Wegovy pill starts at $149/month for lower doses.
How much does Zepbound cost without insurance? LillyDirect vials start at $349/month for cash-pay patients. Standard pen pricing at retail runs $1,000-$1,500/month without a savings card. Compounded tirzepatide programs run $200-$500/month depending on the provider.
Are online weight loss programs legitimate? Some are, some aren’t. Legitimate programs have licensed prescribers listed with credentials, a named and verified pharmacy partner, a genuine consultation step, transparent pricing, and ongoing monitoring. Skip any program that skips the medical evaluation or can’t tell you which pharmacy prepares the medication.
Which medication leads to the most weight loss? Based on current clinical trial data, tirzepatide (Zepbound) produces the highest average weight loss. In the SURMOUNT-5 head-to-head trial, tirzepatide produced 20.2% average weight loss versus 13.7% with semaglutide at 72 weeks. The new 7.2 mg Wegovy HD formulation is also showing around 21% average loss in STEP UP data, making the gap narrower at very high doses.
Can I switch from Ozempic to Wegovy? Yes. Both contain semaglutide, but Wegovy is dosed higher for weight management. Switching from Ozempic to Wegovy typically involves adjusting your dose with your provider’s guidance. This article on oral vs. injectable semaglutide covers some of the clinical trade-offs.
Can I switch from Wegovy to Zepbound? Yes. If you’ve plateaued on semaglutide or want to try the dual-mechanism tirzepatide, your provider can evaluate whether switching makes sense and manage the transition. Our comparison of tirzepatide vs. semaglutide covers the clinical considerations.
How quickly can I receive medication after approval? Most patients receive their first supply within 5-10 business days from approval. That includes 1-2 days for provider review, 1-3 days for pharmacy fulfillment, and 3-5 days for standard shipping.
Do online programs include nutrition coaching? It depends on the program. Noom and Mochi Health include structured behavioral coaching. InjectCo and Henry Meds focus on clinical monitoring and dose management. If coaching is important to you, confirm what’s included before you sign up.
What should I look for in an online GLP-1 program? Licensed prescribers with visible credentials, a named pharmacy partner (503A or 503B), transparent all-in pricing, a real consultation step, ongoing dose monitoring, and a way to reach a real person when something comes up. Six criteria. Programs that check all six are the ones worth trusting.
